09:50 AM EST - Microbix Biosystems Inc. : Reports results for its year ended September 30, 2021 with record sales and earnings, plus progress upon its strategic goal of increasing the proportion of revenues derived from medical devices. 2021 revenues were up 77% from 2020, achieving a record level of $18.6 million. Stronger sales and improved gross margins led to an operating income of $4,836,595 and net income of $3,233,390 versus an operating loss of $524,601 and a net loss of $6,227,525 in 2020. Microbix Biosystems Inc
shares T.MBX are trading up $0.03 at $0.81.
